PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 29, 2026Applied Biochemistry and Biotechnology0 citationsOpen Access

Immunomodulatory Effects of Huaier Extract on Th1/Th2 Polarization Through IL-33/ST2 Axis Regulation in Allergic Rhinitis Pathogenesis

View Full Paper
RYRong-gang YangYLYun-song Li熊熊宇

Key Points

  • To evaluate the immunomodulatory effects of Huaier extract on allergic rhinitis and its mechanisms.
  • Established an OVA-induced allergic rhinitis mouse model with BALB/c mice
  • Evaluated nasal symptoms and conducted histopathological assessments
  • Measured sIgE, Th1/Th2-associated cytokines, and pro-inflammatory mediators using ELISA
  • Assessed IL-33/ST2 pathway proteins via immunohistochemistry
  • Huaier reduced nasal symptom scores compared to the Model group
  • Huaier's efficacy was comparable to dexamethasone
  • Huaier ameliorated the abnormal activation of the IL-33/ST2 pathway
  • Treatment increased Th1 cytokines and decreased Th2 cytokines and OVA-sIgE

Abstract

This study aims to systematically evaluate the immunomodulatory effects of Huaier extract in allergic rhinitis, as well as the underlying mechanisms by which it regulates T helper 1 (Th1) / T helper 1 (Th2) cell imbalance to exert its therapeutic effects. An ovalbumin (OVA)-induced allergic rhinitis mouse model was established. Twenty-four 6-week-old female BALB/c mice were randomly assigned to four groups (n = 6 per group): Control (phosphate-buffered saline PBS only), OVA-sensitized/challenged (Model), OVA + dexamethasone (Dex, 1 mg/kg), and OVA + Huaier extract (Huaier, 50 mg/kg). Intraperitoneal sensitization was conducted on days 1, 7, and 14 using 200 µl of PBS containing 50 µg OVA and 2 mg aluminum hydroxide (alum). From days 21 to 27, the Model, Dex, and Huaier groups underwent alternate-day intranasal OVA challenges, with concurrent daily intranasal treatments: Huaier extract for the Huaier group, dexamethasone for the Dex group, and PBS for the Model group. On day 27, nasal symptoms in the mice were recorded. The following day (day 28), blood samples and nasal mucosal tissues were collected for subsequent analyses. Nasal mucosal histopathology was assessed via hematoxylin-eosin (H&E) staining. Serum levels of specific immunoglobulin E (sIgE), Th1/Th2-associated cytokines, and pro-inflammatory mediators were measured using enzyme-linked immunosorbent assay (ELISA). Th1/Th2-related cytokines and proteins in the IL-33/ST2 pathway were evaluated via immunohistochemistry. Huaier reduced nasal symptom scores. Specifically, we found that after treatment with Huaier or dexamethasone (Dex), the symptom scores of mice (3.33 ± 0.52 and 3.17 ± 0.75, respectively) were significantly lower compared with the Model group (P 0.05). Huaier also ameliorated the abnormal activation of the IL-33/ST2 pathway in mice with allergic rhinitis and alleviated nasal inflammation. This anti-inflammatory effect was associated with increased levels of suppressed Th1 cytokines, alongside decreased levels of elevated Th2 cytokines, OVA-specific immunoglobulin E (OVA-sIgE), IL-33, and ST2. In a murine model of allergic rhinitis, Huaier extract attenuated inflammatory responses and restored Th1/Th2 immune balance. This therapeutic effect may be mediated through regulation of the IL-33/ST2 signaling pathway.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yang et al. (2026) studied this question.

synapsesocial.com/papers/69f154e0879cb923c4945308https://doi.org/10.1007/s12010-026-05706-w
Ask AI
Helpful
Bookmark
Share
View Full Paper